12th Eilat Conference on new Antiepileptic Drugs, Madrid, Spain
From young children to the elderly, epilepsy affects more than 6 million people in Europe. Studies suggest that if treated properly up to 70% of people with the condition could live productive and independent lives.
Attendees will gain an in-depth progress report on new antiepileptic drugs in various stages of development, as well as to present new findings on second-generation treatments.
The event will bring together health professionals, carers, neuropsychologists, physiotherapists and pharmacists to discuss areas of epilepsy research, highlighting problems, concerns and methods to overcome them, with a view to raising awareness and promoting epilepsy research.For further information, please visit:
http://www.eilatxii.com/(opens in new window)